The Treatment of Common Cardiac Arrhythmias

Higgins, 1965, The Electrocardiogram in Epidemiological Studies, Brit. J. Prev. Soc. Med., 19, 53 Ostrander, 1965, Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, Michigan, Circulation, 31, 888, 10.1161/01.CIR.31.6.888 Ostrander, 1966, Serial Electrocardiographic Findings in a Prospective Epidemiological Study, Circulation, 34, 1069, 10.1161/01.CIR.34.6.1069 Nevins, 1974, The Treatment of Acute Myocardial Infarction, Med. Clin. North Am., 38, 435, 10.1016/S0025-7125(16)32170-8 Epstein, 1972, Atropine and Myocardial Infarction, Circulation, 45, 1273, 10.1161/01.CIR.45.6.1273 Massumi, 1972, Ventricular Fibrillation and Tachycardia after Atropine for Treatment of Bradycardia, New Eng. J. Med., 287, 336, 10.1056/NEJM197208172870706 Epstein, 1973, The Early Phase of Myocardial Infarction: Pharmacologic Aspects of Therapy, Ann. Intern. Med., 78, 818, 10.7326/0003-4819-78-6-918 Marako, 1971, Factors Influencing Infarct Size in Experimental Coronary Artery Occlusions, Circulation, 43, 67, 10.1161/01.CIR.43.1.67 Singh, 1974, Beta Adrenergic Receptor Blocking Drugs in Cardiac Arrhythmias, Drugs, 7, 426, 10.2165/00003495-197407060-00004 Katz, 1956 Hillestad, 1971, Quinidine in Maintenance of Sinus Rhythm after Electroconversion of Chronic Atrial Fibrillation, A Controlled Clinical Study, Brit. Heart J., 33, 518, 10.1136/hrt.33.4.518 Levi, 1972, Combined Treatment of Atrial Fibrillation with Quinidine and Beta Blockers, Brit. Heart J., 34, 911, 10.1136/hrt.34.9.911 Warner, 1974, Therapy of Common Arrhythmias, Med. Clin. North Amer., 58, 995, 10.1016/S0025-7125(16)32096-X Smith, 1973, Drug Therapy: Digitalis Glycosides, New Eng. J. Med., 288, 719, 10.1056/NEJM197304052881407 Greenblatt, 1973, Pain and CPK Elevation After Intramuscular Digoxin, New Eng. J. Med., 288, 689, 10.1056/NEJM197303292881317 Greenblatt, 1973, Evaluation of Digoxin Bioavailability in Single Dose Studies, New Eng. J. Med., 289, 651, 10.1056/NEJM197309272891302 Koch-Weser, 1974, Bioavailability of Drugs”, New Eng. J. Med., 291, 233, 10.1056/NEJM197408012910505 Smith, 1973, Digitalis”, New Eng. J. Med., 289, 945, 10.1056/NEJM197311012891805 Lindenbaum, 1971, Variation in Biological Availability of Digoxin From Four Preparations, New Eng. J. Med., 285, 1344, 10.1056/NEJM197112092852403 Greenblatt, 1974, Equivalent Bioavailability from Digoxin Elixir and Rapid Dissolution Tablets, JAMA, 229, 1774, 10.1001/jama.1974.03230510048022 Kimble, 1974, Congestive Heart Failure, JAPhA, 14, 362 Jelliffe, 1968, An Improved Method of Digoxin Therapy, Ann. Intern. Med., 69, 703, 10.7326/0003-4819-69-4-703 Clayton, 1974, Reduction of Digitalis Glycoside Intoxication by Rational Dosing Procedures, Amer. J Hosp. Pharm., 31, 855 Doherty, 1966, Digoxin Metabolism in Hypo- and Hyper-Thyroidism, Studies With Tritiated Digoxin, Ann. Intern. Med., 64, 489, 10.7326/0003-4819-64-3-489 Reuning, 1973, Role of Pharmacokinetics in Drug Dosage Adjustment. I Pharmacologic Effect, Kinetics and Apparent Volume of Distribution of Digoxin, J. Clin. Pharmacol., 13 Ewy, 1969, Digoxin Metabolism in the Elderly, Circulation, 39, 449, 10.1161/01.CIR.39.4.449 Prindle, 1971, Influence of Extracellular Potassium Concentration on Myocardial Uptake and Inotropic Effect of Tritiated Digoxin, Circ. Res., 28, 337, 10.1161/01.RES.28.3.337 Kastor, 1967, Recognition of Digitalis Intoxication in the Presence of Atrial Fibrillation, Ann. Intern. Med., 67, 1045, 10.7326/0003-4819-67-5-1045 Karliner, 1972, Digitalis Treatment of Acute Myocardial Infarction, Circulation, 45, 891, 10.1161/01.CIR.45.4.891 Marcus, 1969, Use of Digitalis in Acute Myocardial Infarction, Heart Bull., 18, 106 Bigger, 1972, Digitalis Toxicity: Drug Interactions Promoting Toxicity and the Management of Toxicity, Seminars in Drug Treatment, 2, 147 Ewy, 1971, Digoxin Metabolism in Obesity, Circulation, 44, 810, 10.1161/01.CIR.44.5.810 Hernandez, 1969, Pharmacodynamics of 3H-Digoxin in Infants, Pediatrics, 44, 418 Rogers, 1972, Serum Digoxin Concentrations in the Human Fetus, Neonate, and Infant, New Eng. J. Med., 287, 1010, 10.1056/NEJM197211162872003 Heizer, 1971, Absorption of Digoxin in Patients with Malabsorption Syndromes”, New Eng. J. Med., 285, 257, 10.1056/NEJM197107292850504 Lindenbaum, 1972, Impairment of Digoxin Absorption by Neomycin, Clin. Res., 20, 410 Bazzano, 1972, Effect of Digitalis-Binding Resins on Cardiac Glycoside Plasma Levels, Clin. Res., 20, 24 Goldfinger, 1970, Malabsorption of Digoxin in Malabsorption Syndromes, Gastroenterology, 58, 952 Bazzano, 1972, Digitalis Intoxication: Treatment with a New Steroid Binding Resin, JAMA, 220, 828, 10.1001/jama.1972.03200060054009 Boston Collaborative Drug Surveillance Program, 1974, Hospital Admissions Due to Adverse Drug Reactions”, Arch. Intern. Med., 134, 219, 10.1001/archinte.1974.00320200029002 Jelliffe, 1972, Reduction of Digitalis Toxicity by Computer Assisted Glycoside Regimens, Ann. Intern. Med., 77, 891, 10.7326/0003-4819-77-6-891 Hurwitz, 1969, Intensive Hospital Monitoring of Adverse Reactions to Drugs”, Brit. Med. J., 1, 531, 10.1136/bmj.1.5643.531 Ogilvie, 1972, An Educational Program in Digitalis Therapy, JAMA, 222, 50, 10.1001/jama.1972.03210010032007 Church, 1962, Deliberate Digitalis Intoxication, Ann. Intern. Med., 57, 946, 10.7326/0003-4819-57-6-946 Chung, 1970, Digitalis Induced Cardiac Arrhythmias, Amer. Heart J., 79, 845, 10.1016/0002-8703(70)90374-1 Duhme, 1974, Reduction of Digoxin Toxicity Associated with Measurement of Serum Levels: A Report From the Boston Collaborative Drug Surveillance Program”, Ann. Intern. Med., 80, 516, 10.7326/0003-4819-80-4-516 Peck, 1973, Computer Assisted Digoxin Therapy, New Eng. J. Med., 289, 441, 10.1056/NEJM197308302890902 Wagner, 1974, Correlation of Plasma Levels of Digoxin in Cardiac Patients with Dose and Measures of Renal Function, Clin. Pharm. Ther., 15, 291, 10.1002/cpt1974153291 Mason, 1970, The Clinical Pharmacology and Therapeutic Applications of the Antiarrhythmic Drugs, Clin. Pharm. Ther., 11, 460, 10.1002/cpt1970114460 Greenblatt, 1974, Adverse Reactions to Beta Adrenergic Receptor Blocking Drugs: A Report from the Boston Collaborative Drug Surveillance Program, Drugs, 7, 118, 10.2165/00003495-197407010-00008 Conway, 1968, Cardiac Failure in Patients with Valvular Heart Disease and After Use of Propranolol to Control Atrial Fibrillation, Brit. Med. J., 2, 213, 10.1136/bmj.2.5599.213 Shand, 1974, Individualization of Propranolol Therapy, Med. Clin. North Am., 58, 1063, 10.1016/S0025-7125(16)32102-2 Patterson, 1970, The Pharmacodynamics and Metabolism of Propranolol in Man, Pharmacologia Clinica, 2, 127, 10.1007/BF00420338 Shand, 1972, The Disposition of Propranolol, I. Elimination During Oral Absorption in Man, Pharmacology, 7 Evans, 1973, Disposition of Propranolol, V. Drug Accumulation and Steady State Concentrations During Chronic Oral Administration in Man, Clin. Pharm. Ther., 14 Shand, 1974, Pharmacokinetic Properties of Beta-Adrenergic Blocking Drugs, Drugs, 7, 39, 10.2165/00003495-197407010-00003 Prichard, 1969, Treatment of Hypertension with Propranolol, Brit. Med. J., 1, 7, 10.1136/bmj.1.5635.7 Stephen, 1966, Unwanted Effects of Propranolol, Amer. J. Cardiol., 18, 463, 10.1016/0002-9149(66)90071-3 Hinskelwood, 1969, Hallucinations and Propranolol, Brit. Med. J., 2, 445, 10.1136/bmj.2.5654.445 Resnekov, 1970, Electroversion of Cardiac Dysrhythmias, Amer. Heart J., 79, 581, 10.1016/0002-8703(70)90277-2 Radford, 1968, Long Term Results of D.C. Reversion of Atrial Fibrillation”, Brit. Heart J, 30, 91, 10.1136/hrt.30.1.91 Hall, 1968, Factors Affecting Cardioversion of Atrial Arrhythmias with Special Reference to Quinidine, Brit. Heart J., 30, 84, 10.1136/hrt.30.1.84 Lown, 1971, Approaches to Sudden Death from Coronary Heart Disease, Circulation, 44, 130, 10.1161/01.CIR.44.1.130 Thompson, 1956, Quinidine as a Cause of Sudden Death, Circulation, 14, 757, 10.1161/01.CIR.14.5.757 Lown, 1967, Electrical Reversion of Cardiac Arrhythmias, Brit. Heart J., 29, 469, 10.1136/hrt.29.4.469 Sjelky, 1970, Maintenance of Sinus Rhythm after Atrial Defibrillation, Brit. Heart J., 32, 741, 10.1136/hrt.32.6.741 Resnekov, 1971, Electroversion of Lone Atrial Fibrillation and Flutter Including Hemodynamic Studies at Rest and on Exercise, Brit. Heart J., 33, 339, 10.1136/hrt.33.3.339 Cramer, 1968, Early and Late Results of Conversion to Atrial Fibrillation with Quinidine”, Acta Med. Scand., S490, 5 Goldman, 1960, The Management of Chronic Atrial Fibrillation: Indications for and Methods of Conversion to Sinus Rhythm, Prog. Cardiovasc. Dis., 2, 465, 10.1016/S0033-0620(60)80005-9 Sokolow, 1961, The Clinical Pharmacology and Use of Quinidine in Heart Disease, Prog. Cardiovasc. Dis., 3, 316, 10.1016/S0033-0620(61)80033-9 Plaut, 1974, Treatment of Immediate Hypersensitivity Reactions to Drugs, Rational Drug Ther., 8, 1 Selzer, 1964, Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring During Treatment of Chronic Atrial Arrhythmias, Circulation, 30, 617, 10.1161/01.CIR.30.1.17 Moss, 1973 Heisenbuttel, 1970, The Effect of Oral Quinidine on Intraventricular Conduction in Man: Correlation of Plasma Quinidine with Changes in QRS Duration, Amer. Heart J., 80, 453, 10.1016/0002-8703(70)90191-2 Weily, 1972, Pharmacokinetics of Procainamide, Arch. Intern. Med., 130, 366, 10.1001/archinte.1972.03650030046011 Gerhardt, 1969, Quinidine Excretion in Aciduria and Alkaluria”, Ann. Intern. Med., 71, 927, 10.7326/0003-4819-71-5-927 Kessler, 1974, Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function”, New Eng. J. Med., 290, 706, 10.1056/NEJM197403282901303 Conn, 1964, Some Cellular and Metabolic Considerations Relating to the Action of Quinidine as a Prototype Antiarrhythmic Agent, Amer. J. Med., 37, 685, 10.1016/0002-9343(64)90018-X Bellet, 1971, Relation Between Serum Quinidine levels and Renal Function, Amer. J. Cardiol., 27, 368, 10.1016/0002-9149(71)90432-2 Halmos, 1966, Direct Current Conversion of Atrial Fibrillation, Brit. Heart J., 28, 302, 10.1136/hrt.28.3.302 Oram, 1964, Further Experience of Electrical Conversion of Atrial Fibrillation to Sinus Rhythm: Analysis of One-Hundred Patients, Lancet, 1, 1294, 10.1016/S0140-6736(64)91692-7 Skelky, 1966, Direct Current Shock Therapy of Cardiac Arrhythmias, Brit. Heart J., 28, 36 Koch-Weser, 1971, Pharmacokinetics of Procainamide in Man, Ann. N. Y. Acad. Sci., 179, 370, 10.1111/j.1749-6632.1971.tb46914.x Giardina, 1973, Intermittent Intravenous Procainamide to Treat Ventricular Arrhythmias, Ann. Intern. Med., 78, 183, 10.7326/0003-4819-78-2-183 Koch-Weser, 1971, Procainamide Dosage Schedules, Plasma Concentrations and Clinical Effects, JAMA, 215, 1454, 10.1001/jama.1971.03180220036006 Bigger, 1969, The Use of Procainamide and Lidocaine in the Treatment of Cardiac Arrhythmias, Prog. Cardiovasc. Dis., 11, 515, 10.1016/0033-0620(69)90004-8 Friedberg, 1967 Bjerkelund, 1969, The Efficacy of Anticoagulant Therapy in Preventing Embolism Related to D.C. Electrical Conversion of Atrial Fibrillation, Amer. J. Cardiol., 23 Askey, 1962, Embolism and Atrial Fibrillation. The Effect of Restoration of Normal Rhythm by Quinidine, Amer. J. Cardiol., 9 Bigger, 1970, Clinical Use of Antiarrhythmic Drugs, Postgrad. Med., 47, 119, 10.1080/00325481.1970.11698101 Chung, 1971 Lown, 1960, Paroxysmal Atrial Tachycardias with Block, Circulation, 21, 129, 10.1161/01.CIR.21.1.129 Bigger, 1971, Management of Cardiac Problems in Intensive Care Units, Med. Clin. North Amer., 55, 1183, 10.1016/S0025-7125(16)32461-0 Phibbs, 1973 Hatle, 1971, Conservative Treatment of A-V Block in Acute Myocardial Infarction—Results in 105 Consecutive Patients, Brit. Heart J., 33, 595, 10.1136/hrt.33.4.595 Meltzer, 1966, The Incidence of Arrhythmias Associated with Acute Myocardial Infarction, Prog. Cardiovasc. Dis., 9, 50, 10.1016/S0033-0620(66)80021-X Dhurandhar, 1971, Primary Ventricular Fibrillation Complicating Acute Myocardial Infarction, Amer. J. Cardiol., 27, 347, 10.1016/0002-9149(71)90429-2 Koch-Weser, 1971, Antiarrhythmic Prophylaxis in Acute Myocardial Infarction, New Eng. J. Med., 285, 1024, 10.1056/NEJM197110282851811 Koch-Weser, 1969, Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction, New Eng. J. Med., 281, 1253, 10.1056/NEJM196912042812301 Pitt, 1971, Lidocaine Prophylaxis to Patients with Acute Myocardial Infarction, Lancet, 1, 612, 10.1016/S0140-6736(71)91549-2 Bloomfield, 1971, Quinidine for Prophylaxis of Arrhythmias in Acute Myocardial Infarction, New Eng. J. Med., 285, 979, 10.1056/NEJM197110282851801 Schwartz, 1970, Comparative Antiarrhythmic Effects of Intravenously Administered Lidocaine and Procainamide and Orally Administered Quinidine, Amer. J. Cardiol., 26, 520, 10.1016/0002-9149(70)90710-1 Rusy, 1974, Pharmacology of Antiarrhythmic Drugs, Med. Clin. North Amer., 58, 987, 10.1016/S0025-7125(16)32095-8 Anon, 1971, Lidocaine as an Antiarrhythmic Agent”, Med. Letter on Drugs Ther., 13, 1 Kimball, 1968, Aggressive Treatment of Arrhythmias in Acute Myocardial Infarction: Procedure and Results, Prog. Cardiovasc. Dis., 10, 483, 10.1016/0033-0620(68)90001-7 Thomson, 1971, The Influence of Heart Failure, Liver Disease and Renal Failure on the Disposition of Lidocaine in Man, Amer. Heart J., 82, 417, 10.1016/0002-8703(71)90308-5 Gianelli, 1967, Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease, New Eng. J. Med., 277, 1215, 10.1056/NEJM196712072772301 Thomson, 1973, Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans, Ann. Intern. Med., 78, 499, 10.7326/0003-4819-78-4-499 Atkinson, 1974, Individualization of Anticonvulsant Therapy, Med. Clin. North Amer., 58, 1037, 10.1016/S0025-7125(16)32099-5 Wilensky, 1973, Inadequate Serum Levels after Intramuscular Administration of Diphenylhydantoin, Neurology., 23, 318, 10.1212/WNL.23.3.318 Serrano, 1973, Plasma Diphenylhydantoin Values after Oral and Intramuscular Administration of Diphenylhydantoin, Neurology, 23, 311, 10.1212/WNL.23.3.311 Bigger, 1968, Relationship Between the Plasma level of Diphenylhydantoin Sodium and its Cardiac Antiarrhythmic Effects, Circulation, 38, 363, 10.1161/01.CIR.38.2.363 Conn, 1967, The Hemodynamic Effects of Diphenylhydantoin, Amer. Heart J., 73, 500, 10.1016/0002-8703(67)90205-0 Mixter, 1966, Cardiac and Peripheral Vascular Effects of Diphenylhydantoin Sodium, Amer. J. Cardiol., 17, 332, 10.1016/0002-9149(66)90216-5 Glazko, 1969, Metabolic Disposition of Diphenylhydantoin in Normal Human Subjects Following Intravenous Administration, Clin. Pharm. Ther., 10, 498, 10.1002/cpt1969104498 Arnold, 1970, The Rate of Decline of Diphenylhydantoin in Human Plasma, Clin. Pharm. Ther., 11, 121, 10.1002/cpt1970111121 Kutt, 1964, Diphenylhydantoin Metabolism, Blood Levels and Toxicity, Archives of Neurology, 11, 642, 10.1001/archneur.1964.00460240074010 Woodbury, 1972 Blum, 1972, Altered Protein Binding of Diphenylhydantoin in Uremic Plasma, New Eng. J. Med., 286, 109, 10.1056/NEJM197201132860224 Letteri, 1971, Diphenylhydantoin Metabolism in Uremia, New Eng. J. Med., 285, 648, 10.1056/NEJM197109162851202 Darby, 1972, Trial of Combined Intramuscular and Intravenous Lidocaine in Prophylaxis of Ventricular Tachyarrhythmias, Lancet, 1, 817, 10.1016/S0140-6736(72)90801-X Church, 1972, Prophylactic Lidocaine in Acute Myocardial Infarction, Circulation, 46, 52 Lie, 1974, Lidocaine in the Prevention of Primary Ventricular Fibrillation, a Double Blind, Randomized Study of 212 Consecutive Patients, New Eng. J. Med., 291, 1324, 10.1056/NEJM197412192912504 Valentine, 1974, Lidocaine in the Prevention of Sudden Death in the Pre-Hospital Phase of Acute Infarction, a Double Blind Study, New Eng. J. Med., 291, 1327, 10.1056/NEJM197412192912505 Liberthson, 1974, Pre-Hospital Ventricular Defibrillation, New Eng. J. Med., 291, 317, 10.1056/NEJM197408152910701 Koch-Weser, 1972, Serum Drug Concentrations as Therapeutic Guides, New Eng. J. Med., 287, 227, 10.1056/NEJM197208032870505